The global orthotic devices market is forecast to expand steadily through 2035, driven by ageing populations, rising chronic disease prevalence, diabetic foot care demand and the growing use of digital fabrication technologies such as 3D printing, CAD/CAM and digital scanning.
According to a new market outlook from IndexBox, the orthotic devices market is expected to reach an index level of approximately 165 by 2035, using 2025 as a baseline of 100. This reflects an estimated compound annual growth rate of around 5.2% between 2026 and 2035.
For the orthotics and prosthetics sector, the forecast confirms that orthotic care is moving from a support category into a major global healthcare market. Orthoses are increasingly used across diabetic foot prevention, musculoskeletal rehabilitation, sports injury management, post-surgical recovery, arthritis care, neurological conditions, paediatrics, geriatric mobility and workplace ergonomics.
The IndexBox report defines orthotic devices as externally applied medical appliances used to support, align, prevent or correct deformities, or improve the function of movable body parts. The market includes foot orthotics, ankle-foot orthoses, knee-ankle-foot orthoses, spinal orthoses, upper-limb orthoses, custom-moulded devices, prefabricated supports and soft-goods orthoses. It excludes prosthetic limbs, internal orthopaedic implants and general mobility aids such as canes or walkers.
For IMEA CPO readers, the market outlook is important because it shows how demand is shifting toward prevention, long-term condition management and patient-specific care. Orthotic services are no longer limited to bracing after injury. They are becoming part of chronic disease management, fall prevention, rehabilitation pathways and digital healthcare delivery.
One of the strongest growth drivers is diabetic foot care, which IndexBox estimates represents around 28% of orthotic device demand. Custom insoles, offloading footwear and pressure redistribution devices are increasingly important in preventing ulcers and reducing amputation risk. IndexBox notes that around 540 million adults are living with diabetes globally in 2026, with the number projected to exceed 700 million by 2035.
This is highly relevant for the Middle East, Africa and South Asia, where diabetes prevalence, late presentation and uneven access to specialist foot care continue to create major amputation-prevention challenges. Diabetic foot orthotics, therapeutic footwear, offloading devices, pressure mapping and regular foot screening should therefore be viewed as essential parts of public health and rehabilitation planning.
The report also identifies sports medicine and injury prevention as a major segment, estimated at 22% of demand. Orthotic devices such as ankle braces, knee supports and custom foot orthoses are widely used to prevent recurrent injuries, support return to activity and manage biomechanical stress. This market is expected to benefit from increased sports participation, active ageing and wider use of gait analysis and wearable monitoring.
Post-surgical rehabilitation accounts for an estimated 20% of demand, with orthoses used after procedures such as knee arthroplasty, ACL reconstruction and spinal fusion. Adjustable braces and controlled-motion orthoses are becoming more important as clinical pathways move toward earlier mobilisation and outpatient recovery.
The arthritis and pain management segment is also significant, estimated at 18% of demand. Orthotic devices are used to offload joints, improve alignment, reduce pain and support function in people with osteoarthritis, rheumatoid arthritis and degenerative musculoskeletal conditions. As populations age, this segment is expected to remain a major growth area.
For geriatric and neurological rehabilitation, IndexBox estimates a 12% market share, with strong growth linked to stroke, Parkinson’s disease, multiple sclerosis, cerebral palsy and fall-risk management. AFOs, KAFOs and spinal supports play an important role in improving gait, stability, posture and safety for people with neurological or age-related mobility impairment.
Technology is another major theme. IndexBox highlights the growing role of 3D printing, CAD/CAM, digital orthotic design, smart materials, pressure sensors, IoT connectivity and remote fitting models. These technologies are reshaping product development and enabling more personalised, cost-effective orthotic solutions.
For IMEA countries, digital fabrication could be particularly important. Many rehabilitation systems face shortages of trained orthotists, long travel distances, limited workshop capacity and uneven access outside major cities. Digital scanning, central fabrication, 3D-printed insoles, digital AFO design and tele-rehabilitation support may help improve service reach if implemented with proper clinical governance and local training.
The regional outlook also deserves attention. IndexBox identifies Asia-Pacific as the largest and fastest-growing regional market, with an estimated 32% share, driven by ageing populations in Japan, China and South Korea, rising diabetes prevalence and expanding healthcare infrastructure. India and Southeast Asia are identified as important growth opportunities due to improving healthcare access and increasing awareness of orthotic benefits.
The Middle East and Africa region is currently smaller, estimated at 6% of the global market, but IndexBox describes it as growing, with demand concentrated in GCC countries and South Africa. Growth is being supported by healthcare infrastructure investment, diabetes prevalence and road traffic injuries.
This creates a clear opportunity for regional O&P providers, distributors and manufacturers. Orthotic demand in the IMEA region is likely to grow in several areas:
However, growth will not be automatic. IndexBox also identifies major constraints, including reimbursement limitations, regulatory fragmentation, price sensitivity in low- and middle-income markets, and shortages of skilled orthotists and prosthetists.
For IMEA CPO, the workforce issue may be the most important of all. Orthotic products can be distributed widely, but clinical outcomes depend on correct assessment, prescription, fitting, adjustment, user training and follow-up. A market can grow in commercial value without necessarily improving patient care unless workforce development and clinical standards grow alongside it.
The report lists major global participants including Essity, DJO / Enovis, Össur, Ottobock, Bauerfeind, Medi, Thuasne, Breg, Fillauer and Hanger. This reflects a market that includes large multinational manufacturers, specialist orthotic companies, O&P component suppliers and patient-care networks.
For regional suppliers and local manufacturers, this competitive landscape presents both opportunity and pressure. International brands are likely to expand into growth markets, but local providers may have advantages in affordability, service access, cultural understanding, repairability and public-sector relationships. The strongest models may combine global technology with local clinical delivery.
The IndexBox forecast should therefore be read as more than a market-growth story. It is a signal that orthotic care is becoming more central to the management of chronic disease, ageing, injury recovery and rehabilitation. For the IMEA region, the question is whether health systems can build the clinical, technical and reimbursement infrastructure needed to meet that demand responsibly.
The coming decade is likely to bring more personalised orthotic devices, more digital workflows, more smart monitoring and more demand for preventive care. But the foundation will remain the same: trained professionals, appropriate prescription, patient education, follow-up and access.
For IMEA’s orthotics and prosthetics community, the message is clear. Orthotic devices are set for sustained global growth through 2035. The opportunity is not only commercial. It is clinical and public health-driven: preventing diabetic foot complications, supporting older adults, improving neurological rehabilitation, reducing pain, enabling recovery and helping patients remain mobile, independent and active.